SENSEX NIFTY

Breast Cancer Drug

Apr 30, 2016 at 13:16 | Source: PTI
"National Pharmaceutical Pricing Authority (NPPA) has fixed/revised ceiling prices of 54 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016 and retail price of two formulations under DPCO, 2013," the regulator said in a statement.
Apr 26, 2016 at 22:08 | Source: PTI
The Delhi High Court has allowed pharma firms, Biocon Ltd and Mylan Pharmaceuticals Pvt Ltd, to continue with manufacture and marketing of their breast cancer drug under their brand names 'CANMAb' and 'HERTRAZ'.
Apr 26, 2016 at 20:00 | Source: PTI
Biotechnology firm Biocon today said its product portfolio will not be affected by an order of the Delhi High Court that prevented the company from calling its breast cancer medicine Trastuzumab as a biosimilar of Roche's Herceptin.
Apr 22, 2016 at 20:32 | Source: PTI
Manufacturers of Ayurvedic,Siddha and Unani drugs cannot claim treatment of cancer, TB,diabetes and infertility besides a number of other conditions,according to a proposed government law.
Apr 15, 2016 at 09:48 | Source: PTI
"NPPA has fixed ceiling prices of 70 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016, and retail price of two formulations under DPCO, 2013," NPPA said in a statement.
Apr 01, 2016 at 12:46 | Source: PTI
"Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market carboplatin injection, 10mg/ml in 5ml, 15ml and 45ml," Cadila Healthcare said in a BSE filing.
Mar 28, 2016 at 09:58 | Source: Moneycontrol.com
Glenmark Pharmaceuticals has received USFDA approval for Bendamustine Hydrochloride for Injection, 25 mg/vial and 100 mg/vial, which is used for Cancer.
Mar 09, 2016 at 16:34 | Source: PTI
"Zydus Cadila has received the tentative approval from the United States Food and Drug Administration (USFDA) to market Clofarabine injection 20mg/20ml vials," Cadila Healthcare said in a BSE filing
Mar 09, 2016 at 14:03 | Source: Moneycontrol.com
"Zydus Cadila has received tentative approval from the United States Food and Drug Administration to market Clofarabine injection 20mg/20ml vials," says the Ahmedabad-based pharma company in its filing.
Mar 09, 2016 at 13:00 | Source: PTI
The five drugs are for treatment of cancer or other major diseases, and are very expensive as they are patented or imported, Li Bin head of National Health and Family Planning Commission said today.
Messages on Breast Cancer Drug »

Khushi1979

New Member

0 Follower

GAIL  

Source:----BS:----) Strong growth prospects: In Biocon, investors see a blockbuster pipeline US nod to application for breast cancer drug is latest positive for the stock Ujjval Jauhari | New Delhi January 18, 2017 Last Updated at 10:53 IST

10.55 AM Jan 19th

k.v.renga

Platinum Member

1434 Followers

Biocon  

Source:----BS:----) Strong growth prospects: In Biocon, investors see a blockbuster pipeline US nod to application for breast cancer drug is latest positive for the stock Ujjval Jauhari | New Delhi January 18, 2017 Last Updated at 10:53 IST

9.48 PM Jan 18th

Web Messenger

Platinum Member

369172 Followers

News Now  

Source:Wall Street Journal - By Marta Falconi ZURICH (Dow Jones)--Positive fresh data on Roche Holding AG's (ROG.VX) newest breast cancer drug is expected to be displayed in the US next month at a high-profile medical meeting. Roche is planning to present additional data from key

4.43 PM May 22nd 2012

Web Messenger

Platinum Member

369172 Followers

News Now  

Source:Bloomberg - An experimental breast cancer drug from Roche Holding AG (ROG) that carries chemotherapy directly into malignant cells while bypassing healthy ones delayed tumors longer and with fewer side effects than an established therapy.

12.31 AM Jun 8th 2012

Web Messenger

Platinum Member

369172 Followers

News Now  

Source:Forbes - An experimental breast cancer drug being developed by tiny Celldex Therapeutics of Needham., Mass., appeared to show a potent tumor-shrinking effect in four women who had both an especially hard-to-treat form of breast cancer and whose tumors had high levels of the protein targeted

7.25 PM May 27th 2012

Web Messenger

Platinum Member

369172 Followers

News Now  

Source:Forbes - An experimental breast cancer drug being developed by tiny Celldex Therapeutics of Needham., Mass., appeared to show a potent tumor-shrinking effect in four women who had both an especially hard-to-treat form of breast cancer and whose tumors had high levels of the protein targeted

12.55 PM May 27th 2012

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.